Back

A multi-center study comparing leadless pacemaker vs. standard pacemaker in patients with indication to ablate and pace for atrial fibrillation (LEAD-AP)

13 April 2026 (13:30 - 14:15)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation in clinical practice Rate Control EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Ingrid Overeinder

University Hospital (UZ) Brussels, Brussels (Belgium)

6 More presentations in this session

Presentation thumbnail
Non-invasive characterization of atrial cardiomyopathy using strain and selective epicardial adipose tissue in persistent atrial fibrillation
Doctor A. Grosse (Jena, DE)
Abstract Slides Video
Presentation thumbnail
Long-term persistence of superior vena cava impact following pulsed-field ablation of the right pulmonary veins
Doctor H. Matsuura (Suita, JP)
Abstract Slides Video
Presentation thumbnail
Atrial substrate and electrogram characterization in patients with atrial fibrillation and hypertrophic cardiomyopathy
Doctor G. Mascia (Genova, IT)
Abstract Slides Video
Presentation thumbnail
Feasibility and outcomes of pulmonary vein isolation after transcatheter tricuspid valve intervention in patients with atrial fibrillation
Doctor J. Schipper (Cologne, DE)
Abstract Slides Video
Presentation thumbnail
Ultra-low voltage zones as a marker of atrial cardiomyopathy: insights from high-density mapping
Doctor A. Spadotto (Bologna, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation in clinical practice

The Event

Event poster

EHRA 2026

13 April 2026 13:30 CET
You may be interested in
thumbnail
Congress Presentation
12 years of leadless pacing: what did we learn?
thumbnail
Congress Presentation
Discussant review - ARRIVE Study
thumbnail
Congress Session
Leadless pacemaker

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources